Understanding how certain brain cells are affected in Parkinson's disease

Profiling of Midbrain Neuronal Vulnerability in Parkinson's Disease

NIH-funded research Icahn School of Medicine at Mount Sinai · NIH-11071321

This study is looking at how certain brain cells are affected in people with Parkinson's disease, and it hopes to find new ways to improve treatments by analyzing samples from patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11071321 on NIH RePORTER

What this research studies

This research investigates the vulnerability of specific types of neurons in the midbrain of individuals with Parkinson's disease (PD). By using advanced techniques like single-nucleus RNA sequencing, the study aims to identify and characterize unique populations of neurons that may be affected by the disease. The goal is to better understand the cellular changes that occur in PD, which could lead to improved treatment strategies. Patients may be involved in providing biological samples to help researchers analyze these neuronal populations.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with Parkinson's disease.

Not a fit: Patients with early-stage Parkinson's disease or those without a confirmed diagnosis may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights into Parkinson's disease, potentially improving diagnosis and treatment options for patients.

How similar studies have performed: Previous research using similar techniques has shown promise in understanding neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age associated neurodegenerative diseaseage associated neurodegenerative disorderage dependent neurodegenerative diseaseage dependent neurodegenerative disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.